These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7909078)
21. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia]. Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519 [TBL] [Abstract][Full Text] [Related]
22. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Jönsson EG; Sillén A; Vares M; Ekholm B; Terenius L; Sedvall GC Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):28-34. PubMed ID: 12707934 [TBL] [Abstract][Full Text] [Related]
23. Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia. Serretti A; Macciardi F; Smeraldi E Schizophr Res; 1998 Nov; 34(3):207-10. PubMed ID: 9850987 [TBL] [Abstract][Full Text] [Related]
24. Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia. Zahari Z; Teh LK; Ismail R; Razali SM Psychiatr Genet; 2011 Aug; 21(4):183-9. PubMed ID: 21206399 [TBL] [Abstract][Full Text] [Related]
25. Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis. Zou YF; Wang F; Feng XL; Li WF; Tian YH; Tao JH; Pan FM; Huang F J Affect Disord; 2012 Feb; 136(3):229-37. PubMed ID: 21130502 [TBL] [Abstract][Full Text] [Related]
26. Association study of bipolar disorder using a functional polymorphism (Ser311-->Cys) in the dopamine D2 receptor gene. Craddock N; Roberts Q; Williams N; McGuffin P; Owen MJ Psychiatr Genet; 1995; 5(2):63-5. PubMed ID: 7551964 [TBL] [Abstract][Full Text] [Related]
27. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Lawford BR; Young RM; Swagell CD; Barnes M; Burton SC; Ward WK; Heslop KR; Shadforth S; van Daal A; Morris CP Schizophr Res; 2005 Feb; 73(1):31-7. PubMed ID: 15567074 [TBL] [Abstract][Full Text] [Related]
28. Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia. Chen CH; Wei FC; Koong FJ; Hsiao KJ Biol Psychiatry; 1997 Apr; 41(7):827-9. PubMed ID: 9084902 [No Abstract] [Full Text] [Related]
29. A DRD2 polymorphism predicts PANSS score variability in schizophrenia patients treated with antipsychotics. Voisey J; Swagell CD; Hughes IP; Barnes M; Burton SC; van Daal A; Morris CP; Lawford BR; Young RM Psychiatry Res; 2010 May; 177(3):367-8. PubMed ID: 20388573 [No Abstract] [Full Text] [Related]
30. DRD2 Ser311Cys polymorphism and risk of schizophrenia. Watanabe Y; Shibuya M; Someya T Am J Med Genet B Neuropsychiatr Genet; 2015 Apr; 168B(3):224-8. PubMed ID: 25711927 [No Abstract] [Full Text] [Related]
31. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population. Behravan J; Hemayatkar M; Toufani H; Abdollahian E Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314 [TBL] [Abstract][Full Text] [Related]
32. Response to "DRD2 Ser311Cys polymorphism and risk of schizophrenia". Yao J; Wang BJ Am J Med Genet B Neuropsychiatr Genet; 2015 Apr; 168B(3):223. PubMed ID: 25711779 [No Abstract] [Full Text] [Related]
33. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population. Ambrósio AM; Kennedy JL; Macciardi F; Macedo A; Valente J; Dourado A; Oliveira CR; Pato C Psychiatry Res; 2004 Mar; 125(3):185-91. PubMed ID: 15051179 [TBL] [Abstract][Full Text] [Related]
34. [Lack of association between 141C Ins/Del promoter polymorphism of DRD2 gene and schizophrenia]. Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Hauser J Psychiatr Pol; 2002; 36(3):413-9. PubMed ID: 12149917 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Glatt SJ; Faraone SV; Tsuang MT Mol Psychiatry; 2003 Nov; 8(11):911-5. PubMed ID: 14593428 [TBL] [Abstract][Full Text] [Related]
36. The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis. Liu L; Fan D; Ding N; Hu Y; Cai G; Wang L; Xin L; Xia Q; Li X; Xu S; Xu J; Yang X; Zou Y; Pan F Neurosci Lett; 2014 Nov; 583():43-8. PubMed ID: 25240594 [TBL] [Abstract][Full Text] [Related]
37. The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia. Liou YJ; Lai IC; Liao DL; Chen JY; Lin CC; Lin CY; Chen CM; Bai YM; Chen TT; Wang YC Schizophr Res; 2006 Sep; 86(1-3):323-5. PubMed ID: 16769201 [No Abstract] [Full Text] [Related]
38. [Association of schizophrenia with a promoter polymorphism in the dopamine D2 receptor gene]. Peng DH; Wang GH; Cheng ZL; Zhang DX; Jiang KD Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):94-5. PubMed ID: 15696493 [TBL] [Abstract][Full Text] [Related]
39. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia. Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450 [TBL] [Abstract][Full Text] [Related]
40. [The Cys allele of the DRD2 (Ser311Cys polymorphism) is associated with schizophrenia and worse sustained attention in patients]. Golimbet VE; Lebedeva IS; Monakhov MV; Korovaĭtseva GI; Lezheĭko TV; Abramova LI; Kaleda VG; Karpov VL Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):67-70. PubMed ID: 19770837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]